HLA rs3129882 variant in Chinese Han patients with late-onset sporadic Parkinson disease

Neuroscience Letters

Volumn 501, Issue 3, 2011, Pages 185-187

  Guo, Yi ^a,b   Deng, Xiong ^a   Zheng, Wen ^a   Xu, Hongbo ^a   Song, Zhi ^a   Liang, Hui ^a   Lei, Jin ^a   Jiang, Xuhong ^a   Luo, Ziqiang ^b   Deng, Hao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b The First People s Hospital of Changde City)   (China)

Author keywords

Association; HLA DRA; Late onset sporadic Parkinson disease; Rs3129882

Indexed keywords

HLA ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; ARTICLE; CHINA; CHINESE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL;

AGE OF ONSET; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HLA-DR ALPHA-CHAINS; HUMANS; INTRONS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC;

EID: 79961211173     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.05.245     Document Type: Article

References (26)

1. Chen H., Jacobs E., Schwarzschild M.A., McCullough M.L., Calle E.E., Thun M.J., Ascherio A. Nonsteroidal anti-inflammatory drug use and the risk for Parkinson's disease. Ann. Neurol. 2005, 58:963-967.
2. Chiba S., Matsumoto H., Saitoh M., Kasahara M., Matsuya M., Kashiwagi M. A correlation study between serum adenosine deaminase activities and peripheral lymphocyte subsets in Parkinson's disease. J. Neurol. Sci. 1995, 132:170-173.
3. Deng H., Le W.D., Guo Y., Huang M.S., Xie W.J., Jankovic J. Extended study of A265G variant of HS1BP3 in essential tremor and Parkinson's disease. Neurology 2005, 65:651-652.
4. Deng H., Yang H., Le W., Deng X., Xu H., Zhu S., Xie W., Jankovic J. Examination of the MASH1 gene in patients with Parkinson's disease. Biochem. Biophys. Res. Commun. 2010, 392:548-550.
5. Fiszer U., Mix E., Fredrikson S., Kostulas V., Link H. Parkinson's disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood. Acta Neurol. Scand. 1994, 90:160-166.
6. Hamza T.H., Zabetian C.P., Tenesa A., Laederach A., Montimurro J., Yearout D., Kay D.M., Doheny K.F., Paschall J., Pugh E., Kusel V.I., Collura R., Roberts J., Griffith A., Samii A., Scott W.K., Nutt J., Factor S.A., Payami H. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat. Genet. 2010, 42:781-785.
7. International Multiple Sclerosis Genetics Consortium, Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., de Bakker P.I., Gabriel S.B., Mirel D.B., Ivinson A.J., Pericak-Vance M.A., Gregory S.G., Rioux J.D., McCauley J.L., Haines J.L., Barcellos L.F., Cree B., Oksenberg J.R., Hauser S.L. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 2007, 357:851-862.
8. International Parkinson Disease Genomics Consortium, Nalls M.A., Plagnol V., Hernandez D.G., Sharma M., Sheerin U.M., Saad M., Simón-Sánchez J., Schulte C., Lesage S., Sveinbjörnsdóttir S., Stefánsson K., Martinez M., Hardy J., Heutink P., Brice A., Gasser T., Singleton A.B., Wood N.W. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011, 377:641-649.
9. Jankovic J. Parkinson's disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 2008, 79:368-376.
10. Kay D.M., Factor S.A., Samii A., Higgins D.S., Griffith A., Roberts J.W., Leis B.C., Nutt J.G., Montimurro J.S., Keefe R.G., Atkins A.J., Yearout D., Zabetian C.P., Payami H. Genetic association between alpha-synuclein and idiopathic Parkinson's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B:1222-1230.
11. Korman A.J., Auffray C., Schamboeck A., Strominger J.L. The amino acid sequence and gene organization of the heavy chain of the HLA-DR antigen: homology to immunoglobulins. Proc. Natl. Acad. Sci. U.S.A. 1982, 79:6013-6017.
12. Komar A.A. Genetics. SNPs, silent but not invisible. Science 2007, 315:466-467.
13. Lesage S., Brice A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet. 2009, 18:R48-R59.
14. McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988, 38:1285-1291.
15. McGeer P.L., McGeer E.G. Glial reactions in Parkinson's disease. Mov. Disord. 2008, 23:474-483.
16. McGeer P.L., Schwab C., Parent A., Doudet D. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Ann. Neurol. 2003, 54:599-604.
17. Montgomery S.B., Sammeth M., Gutierrez-Arcelus M., Lach R.P., Ingle C., Nisbett J., Guigo R., Dermitzakis E.T. Transcriptome genetics using second generation sequencing in a Caucasian population. Nature 2010, 464:773-777.
18. Orr C.F., Rowe D.B., Mizuno Y., Mori H., Halliday G.M. A possible role for humoral immunity in the pathogenesis of Parkinson's disease. Brain 2005, 128:2665-2674.
19. Ott J. Methods of analysis and resources available for genetic trait mapping. J. Hered. 1999, 90:68-70.
20. Powers K.M., Kay D.M., Factor S.A., Zabetian C.P., Higgins D.S., Samii A., Nutt J.G., Griffith A., Leis B., Roberts J.W., Martinez E.D., Montimurro J.S., Checkoway H., Payami H. Combined effects of smoking, coffee and NSAIDs on Parkinson's disease risk. Mov. Disord. 2008, 23:88-95.
21. Reynolds A.D., Stone D.K., Hutter J.A., Benner E.J., Mosley R.L., Gendelman H.E. Regulatory T cells attenuate th17 cell-mediated nigrastriatal dopaminergic neurodegeneration in a model of Parkinson' disease. J. Immunol. 2010, 184:2261-2271.
22. Stranger B.E., Nica A.C., Forrest M.S., Dimas A., Bird C.P., Beazley C., Ingle C.E., Dunning M., Flicek P., Koller D., Montgomery S., Tavaré S., Deloukas P., Dermitzakis E.T. Population genomics of human gene expression. Nat. Genet. 2007, 39:1217-1224.
23. Satake W., Nakabayashi Y., Mizuta I., Hirota Y., Ito C., Kubo M., Kawaguchi T., Tsunoda T., Watanabe M., Takeda A., Tomiyama H., Nakashima K., Hasegawa K., Obata F., Yoshikawa T., Kawakami H., Sakoda S., Yamamoto M., Hattori N., Murata M., Nakamura Y., Toda T. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet. 2009, 41:1303-1307.
24. Tansey M.G., Goldberg M.S. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol. Dis. 2010, 37:510-518.
25. Thi Tran H.T., Takeshima Y., Surono A., Yagi M., Wada H., Matsuo M. A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro. Mol. Genet. Metab. 2005, 85:213-219.
26. Zabetian C.P., Hutter C.M., Factor S.A., Nutt J.G., Higgins D.S., Griffith A., Roberts J.W., Leis B.C., Kay D.M., Yearout D., Montimurro J.S., Edwards K.L., Samii A., Payami H. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Ann. Neurol. 2007, 62:137-144.